Clinical trials show that while fat mass reduction predominates during semaglutide treatment, some lean mass loss does occur
How clinicians read investigational obesity data When clinicians review early or mid-stage obesity data, they usually look at more than the headline weight-loss result
They boost natural growth hormone release, fostering muscle growth, fat loss, and recovery
For many people, traditional weight loss methods dont address the biological factors that contribute to weight gain
The fat loss doesnt cause that decline but it can accelerate a shift that was already in motion
J Am Geriatr Soc 2005, 53, (4), 6959, Lezak, M